Results for zymase
On this page:
 
Dictionary:

zymase

  ('mās', -māz') pronunciation
n.

The enzyme complex in yeasts that catalyzes the breakdown of sugar into alcohol and carbon dioxide.


 
 

The mixture of enzymes in yeast which is responsible for fermentation.

 

Any protein that acts as a catalyst, increasing the rate at which a chemical reaction occurs. The animal body probably contains about 10,000 different enzymes. At body temperature, very few biochemical reactions proceed at a significant rate without the presence of an enzyme. Like all catalysts, an enzyme does not control the direction of the reaction; it increases the rates of the forward and reverse reactions proportionally.

  • activating e. — one that activates a given amino acid by attaching it to the corresponding transfer ribonucleic acid.
  • e. assays — several enzymes are important in clinical pathology. Enzymes characteristic of a tissue are released into the blood when the tissue is damaged, and enzyme levels in the blood can aid in the diagnosis or monitoring of specific diseases. Lipase and amylase levels are useful in pancreatic diseases; alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in liver diseases; and lactate dehydrogenase (LD), AST and creatine kinase (CK) in muscle disease. ALP is also released in bone diseases. Many enzymes have different forms (isoenzymes) in different organs. The isoenzymes can be separated by electrophoresis in order to determine the origin of the enzyme. Isoenzymes of LD, CK and ALP have the most clinical utility.
  • brancher e., branching e. — amylo-(1,4→1,6)-transglycosylase; important in the synthesis of the branched glycogen molecule. Absence of the enzyme causes an increase in the length of the glucose chains and a decrease in the number of branch points in the glycogen molecules.
  • congenital e. deficiency — in humans hundreds of genetic diseases that result from deficiency of a single enzyme are now known. Many of these diseases fall into two large classes. The aminoacidopathies, e.g. phenylketonuria (PKU), result from deficiency of an enzyme in the major pathway for the metabolism of a specific amino acid. The amino acid accumulates in the blood, and it or its metabolites are excreted in the urine. The lysomal storage diseases, e.g. gangliosidosis, mannosidosis, result from deficiency of a lysomal enzyme and the accumulation of the substance degraded by that enzyme in lysosomes of cells throughout the body. The stored material is usually a complex substance, such as glycogen, a sphingolipid or a mucopolysaccharide. Many similar diseases are now identified in animals and are to be found under the specific name of each disease.
  • constitutive e. — one produced by a microorganism regardless of the presence or absence of the specific substrate acted upon.
  • core e. — the smallest aggregate of an enzyme's subunits that has enzymatic activity.
  • debrancher e., debranching e. — dextrin-1,6-glucosidase: an enzyme that acts to move glucose residues of the glycogen molecule, and is important in glycogenolysis.
  • induced e., inducible e. — one whose production requires or is stimulated by a specific small molecule, the inducer, which is the substrate of the enzyme or a compound structurally related to it.
  • e. induction — the effect some compounds such as phenobarbitone and phenytoin have in increasing the activity of microsomal hepatic enzymes. This may cause alterations in the metabolism of concurrently administered drugs.
  • microsomal e's — those associated with the endoplasmic reticulum of cells, particularly of the liver.
  • proteolytic e. — one that catalyzes the hydrolysis of proteins and various split products of proteins, the final product being small peptides and amino acids.
  • repressible e. — one whose rate of production is decreased as the concentration of certain metabolites is increased.
  • respiratory e's — enzymes of the mitochondria, e.g. cytochrome oxidase, which serve as catalysts for cellular oxidations.
  • restriction e's — see restriction endonuclease.
 
Wikipedia: zymase

Zymase is an enzyme complex that catalyzes glycolysis, the fermentation of sugar into ethanol and carbon dioxide. As the conversion takes place, the reaction will gradually slow down. They occur naturally in yeasts. See alcohol dehydrogenase.

Zymase was first isolated from the yeast cell in 1897 by a German chemist named Eduard Buchner who fermented sugar in the laboratory. A British chemist by the name of Sir Arthur Harden divided zymase into two varieties dialyzable and nondialyzable in 1905.

Zymase is also the brand name of the generic enzyme mixture pancrelipase, a dietary supplement containing the enzymes amylase, peptidase, and lipase. It is sold to help digestion in people who do not produce enough of their own digestive enzymes.


 
 

Join the WikiAnswers Q&A community. Post a question or answer questions about "zymase" at WikiAnswers.

 

Copyrights:

Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2007. Published by Houghton Mifflin Company. All rights reserved.  Read more
Food and Nutrition. A Dictionary of Food and Nutrition. Copyright © 1995, 2003, 2005 by A. E. Bender and D. A. Bender. All rights reserved.  Read more
Veterinary Dictionary. Saunders Comprehensive Veterinary Dictionary 3rd Edition. Copyright © 2007 by D.C. Blood, V.P. Studdert and C.C. Gay, Elsevier. All rights reserved.  Read more
Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Zymase" Read more

Search for answers directly from your browser with the FREE Answers.com Toolbar!  
Click here to download now. 

Get Answers your way! Check out all our free tools and products.

On this page:   E-mail   print Print  Link  

 

Keep Reading

Mentioned In: